The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Genius Sports Limited (NYSE: GENI) closed at $9.31 in the last session, up 2.42% from day before closing price of $9.09. In other words, the price has increased by $2.42 from its previous closing price. On the day, 1.27 million shares were traded. GENI stock price reached its highest trading level at $9.31 during the session, while it also had its lowest trading level at $8.9556.
Ratios:
We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 264.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 16, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $7.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Davison Jack bought 100,388 shares for $8.74 per share.
Davison Jack bought 8,202 shares of GENI for $71,617 on Jan 10 ’25. On Jan 08 ’25, another insider, Stevens Eric, who serves as the Officer of the company, bought 13,736 shares for $8.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2129848832 and an Enterprise Value of 1890818944. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.98 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 4.088 whereas that against EBITDA is -42.605.
Stock Price History:
The Beta on a monthly basis for GENI is 2.15, which has changed by 0.24010909 over the last 52 weeks, in comparison to a change of 0.20652604 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $10.33, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is 2.82%, while the 200-Day Moving Average is calculated to be 27.35%.
Shares Statistics:
According to the various share statistics, GENI traded on average about 2.62M shares per day over the past 3-months and 2091360 shares per day over the past 10 days. A total of 211.14M shares are outstanding, with a floating share count of 206.12M. Insiders hold about 9.90% of the company’s shares, while institutions hold 75.06% stake in the company. Shares short for GENI as of 1738281600 were 29680139 with a Short Ratio of 11.31, compared to 1735603200 on 30643550. Therefore, it implies a Short% of Shares Outstanding of 29680139 and a Short% of Float of 17.2.
